Metabolic imprinting effects of specifically designed lipid component

Patent metadata

Field	Value
Publication number	US-9649286-B2
Application number	US-201514954370-A
Country	US
Kind code	B2
Filing date	Nov 30, 2015
Priority date	Jun 16, 2011
Publication date	May 16, 2017
Grant date	May 16, 2017

Abstract

The invention relates to the use of specifically designed lipid component with optimal fatty acid profile, an enhanced portion of the palmitic acid residues in the sn-2 position and present as lipid globules with a phospholipid coating for an early in life diet for improving the development of a healthy body composition, in particular prevention of obesity, later in life.

First claim

The invention claimed is:

1. A method of prevention of obesity, reducing the risk of obesity, treatment of obesity, prevention of diabetes type 2, reducing the risk of occurrence of insulin resistance and improving insulin sensitivity, preventing metabolic syndrome, comprising administering to a preterm and/or small for gestational age infant a nutritional composition comprising carbohydrates, protein and lipid, wherein the lipid is present in the form of lipid globules comprising:
(a) linoleic acid and alpha-linolenic acid in a weight ratio of 2 to 10,
(b) at least 10 wt. % palmitic acid based on total fatty acids, wherein at least 30 wt. % of the palmitic acid is esterified to the sn-2 position of a triglyceride based on total palmitic acid, and
(c) a surface at least partly coated with phospholipids,
wherein the amount of phospholipids present in the nutritional composition being from 0.5 to 20 wt. % phospholipids based on total lipid, and
wherein the nutritional composition is not human milk.

2. The method of claim 1 , wherein the nutritional composition is for feeding a human subject with an age between 0 and 36 months.

3. The method according to claim 2 , wherein the prevention, reduction, improvement is observed when the subject is over 36 months.

4. The method according to claim 1 , wherein the subject is a non-obese human subject.

5. The method according to claim 1 , wherein the composition is a preterm formula, infant formula, follow on formula or growing up milk.

6. The method according to claim 1 , wherein the composition comprises less than 15 wt. % linoleic acid and more than 1 wt. % alpha-linolenic acid based on total fatty acids.

7. The method according to claim 1 , wherein the composition comprises at least 0.15 wt % n-3 LC-PUFA based on total fatty acids selected from the group consisting of DHA, EPA, and DPA.

8. The method according to claim 1 , wherein at least 35 wt. % of the palmitic acid is esterified to the sn-2 position of a triglyceride based on total palmitic acid.

9. The method according to claim 1 , wherein the lipid globules have a volume mode diameter of 1.0 μm or above.

10. The method according to claim 1 , wherein 0.5 to 20 wt. % of the phospholipids derived from mammalian milk based on total lipid.

11. The method according to claim 1 , wherein the composition comprises a core of lipid globules comprising at least 40 wt. % of triglycerides of vegetable origin.

12. The method according to claim 1 , wherein the composition comprises 10 to 50 wt. % lipids based on dry weight of the total composition.

13. The method according to claim 1 , wherein the lipids provide 30 to 60% of the total calories, the protein provides 5 to 20% of the total calories and the digestible carbohydrates provide 25 to 75% of the total calories.

14. The method according to claim 1 , wherein the protein provides 5 to 9% of the total calories.

15. The method according to claim 1 , wherein the composition further comprises non digestible oligosaccharides.

16. The method according to claim 1 , wherein the composition is a powder.

17. A method of improving body composition, the improvement of body composition being selected from the group consisting of increased lean body mass, decreased fat mass relative to total body weight, decreased visceral fat mass relative to total body weight, a decreased visceral fat mass relative to total fat mass, decreased fat accumulation and increased muscle mass, the method comprising administering to a preterm and/or small for gestational age infant a nutritional composition comprising carbohydrates, protein and lipid, wherein the lipid is present in the form of lipid globules comprising:
(a) linoleic acid and alpha-linolenic acid in a weight ratio of 2 to 10,
(b) at least 10 wt. % palmitic acid based on total fatty acids, wherein at least 30 wt. % of the palmitic acid is esterified to the sn-2 position of a triglyceride based on total palmitic acid, and
(c) a surface at least partly coated with phospholipids,
wherein the amount of phospholipids present in the nutritional composition being from 0.5 to 20 wt. % phospholipids based on total lipid, and

wherein the nutritional composition is not human milk.

Assignees

• Nutricia Nv

Inventors

• Van Der Beek Eline Marleen
• Abrahamse-Berkeveld Marieke
• Oosting Annemarie
• Alles Martine Sandra

Classifications

• A61P3/10

  for hyperglycaemia, e.g. antidiabetics · CPC title

• A61P3/04

  Anorexiants; Antiobesity agents · CPC title

• A61P19/10

  for osteoporosis · CPC title

• A61K31/7016

  Disaccharides, e.g. lactose, lactulose (lactobionic acid A61K31/7032) · CPC title

• A23V2002/00

  Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title